Concepedia

Hrishikesh Kale

HK

10

Publications

688

Citations

10

H-Index

2013

Active since

Affiliations

Pharmerit (United States)(Current)

Virginia Commonwealth University

University of Pennsylvania

Yale Cancer Center

Taiho Oncology (United States)

Hrishikesh Kale is an author at Pharmerit (United States) specializing in health sciences, geriatric oncology, and oncology.

ORCID

Top concepts

Publications per year

2013–2020

10

Publications

10

Self‐reported financial burden of cancer care and its effect on physical and mental health‐related quality of life among US cancer survivors

Hrishikesh Kale, Norman V. Carroll · Cancer · 2016 · 345 citations · Full text

Changes in oxycodone and heroin exposures in the National Poison Data System after introduction of extended‐release oxycodone with abuse‐deterrent characteristics

Paul Coplan, Hrishikesh Kale, Lauren Sandstrom et al. · Pharmacoepidemiology and Drug Safety · 2013 · 124 citations · Full text

Reductions in reported deaths following the introduction of extended‐release oxycodone (OxyContin) with an abuse‐deterrent formulation

Nelson E. Sessler, Jerod M. Downing, Hrishikesh Kale et al. · Pharmacoepidemiology and Drug Safety · 2014 · 84 citations · Full text

Assessment of Rates of Acute Adverse Reactions to Gadobenate Dimeglumine: Review of More Than 130,000 Administrations in 7.5 Years

Saeed Fakhran, Lea Alhilali, Hrishikesh Kale et al. · American Journal of Roentgenology · 2015 · 35 citations

Under-use of Hypomethylating Agents in Patients With Higher-risk Myelodysplastic Syndrome in the United States: A Large Population-based Analysis

Shelby Corman, Namita Joshi, Tim Wert et al. · Clinical Lymphoma Myeloma & Leukemia · 2020 · 24 citations · Full text

Rows per page

1–5 of 10